Detalles de la búsqueda
1.
Elective administration in infants of low-dose recombinant activated factor VII (rFVIIa) in cardiopulmonary bypass surgery for congenital heart disease does not shorten time to chest closure or reduce blood loss and need for transfusions: a randomized, double-blind, parallel group, placebo-controlled study of rFVIIa and standard haemostatic replacement therapy versus standard haemostatic replacement therapy.
Blood Coagul Fibrinolysis
; 17(5): 389-95, 2006 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-16788315
Resultados
1 -
1
de 1
1
Próxima >
>>